Ultragenyx and Mereo BioPharma Announce Collaboration and License Agreement for ...

Retrieved on: 2020-12-17 21:00:00

Tags for this article:

Musculoskeletal system

Branches of biology

Osteogenesis imperfecta

Bone

Collagen, type I, alpha 1

Bisphosphonate

Mereo BioPharma Group plc

Ultragenyx Pharmaceutical Inc

United States

Denise Scots-Knight

Click the tags to see associated articles and topics

Ultragenyx and Mereo BioPharma Announce Collaboration and License Agreement for .... View article details on HISWAI: https://www.globenewswire.com/news-release/2020/12/17/2147399/0/en/Ultragenyx-and-Mereo-BioPharma-Announce-Collaboration-and-License-Agreement-for-Setrusumab-in-Osteogenesis-Imperfecta.html

Excerpt

Clinical-stage <b>monoclonal antibody</b> in development for rare genetic bone ... In various mouse models of OI, the use of anti-sclerostin antibodies was ...

Article found on: www.globenewswire.com

View Original Article